NovaResp Technologies Inc.: federal grants and contributions: 23 agreements; $3.3M value; 3 departments; 11 programs.
Assay record ASY-CA-0LQF7YV09U · Cite as: Assay Systems, “NovaResp Technologies Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/novaresp-technologies-inc/
The goal of this project is to de-risk technical aspects related to improving patient adherence via reduction of pressure of therapy through the following steps: 1. Improving the algorithm’s value by proper annotation of data pre-training; and 2. Proof of reduction of the pressure of therapy.
Support clinical testing and verification.
Development of cMAP(TM) (Continuous monitoring of airway pressure) device and algorithm for respiratory monitoring for positive airway pressure (PAP) machines.
Develop a breathing apparatus prototype using core intellectual property
Developing a proprietary tubeless-wireless solution using cMAP for sleep apnea patients
Provide support for engineering design and to hire a project manager
NovaResp Technologies Incorporated is a Canadian based corporation founded in 2016 with the goal of developing adaptive, self-learning airway management and providing truly proactive adaptation to patients’ respiratory needs. The company’s lead product – cMAP™- (Continuous monitoring of airway pressure) is a respiratory monitoring device and algorithm that can help positive airway pressure (PAP) machines respond proactively resulting in a safer, more comfortable solution for patients suffering from Sleep Apnea. The purpose of this project is to optimize cMAP™ to improve accuracy of the predic
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
Engage a Business Development & Productivity Consultant
Engage expertise to design stand-alone hardware for predictive algorithm
International Co-Innovation Action Program (ICAP) project. Co-development partner identification. NovaResp Technologies Inc. is a medical technology company with an AI enabled patented software that makes CPAP machines more comfortable. We are looking to identify co-innovation partners who are interested in improving patient adherence to therapy and other stakeholders (distributors & payers) that are interested in the German and Dutch markets.
Engage consultant for business development and market entry strategies
The technical and market feasibility study will help determine the ideal market pathway for the Firm's technology and the optimum R&D pathway for development of the beta prototype.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Maintenance of the Firm's alpha prototype device and contribute to research and design of miniaturization of the alpha prototype in order to retrofit the hardware and software to current CPAP machines.
In this project the Youth will assist in coordination of studies conducted by NovaResp and help to develop the technology.
The project will support development of intellectual property capacity within the firm.
The project will support development of intellectual property capacity within the firm.
The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
The Project will support development of intellectual property capacity within the Firm.
NovaResp’s primary technology includes an add-on device to be used alongside CPAP machines for patients with sleep apnea, that through personalizing the therapy, improves patients' experience, and consequently, patient compliance. This will reduce morbidity, mortality, and the cost on the healthcare system. The project includes participating in design and development of alfa-prototype.
Subsidy payments to industry for research and development
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.